United States · FDA National Drug Code directory
Spirudio
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87754-0002_537294e5-3647-7e41-e063-6294a90a145a
- Product NDC
- 87754-0002
- Form
- TABLET
- Composition / generic term
- Spirudio
- Labeler
- PROGRESYVUS TYRIMAI MB
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260601
- Source listing expiry
- 20271231
Source-listed ingredients
- LAPINE S-100 IMMUNE GLOBULIN — 30 [hp_C]/U
These values do not establish equivalence or a dose recommendation.
Packages
- 60 U in 1 BOTTLE (87754-0002-1) · 87754-0002-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →